Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer

ClinicalTrials.gov ID: NCT02556632

Public ClinicalTrials.gov record NCT02556632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis

Study identification

NCT ID
NCT02556632
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gary Morrow
Other
Enrollment
191 participants

Conditions and interventions

Interventions

  • Curcumin-based Gel Drug
  • Dermatologic Complications Management Procedure
  • Laboratory Biomarker Analysis Other
  • Placebo Other
  • Questionnaire Administration Other

Drug · Procedure · Other

Eligibility (public fields only)

Age range
21 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 12, 2015
Primary completion
Sep 29, 2016
Completion
Sep 29, 2016
Last update posted
Nov 5, 2017

2015 – 2016

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
Delaware/Christiana Care NCORP Newark Delaware 19713
Heartland NCORP Decatur Illinois 62526
Metro-Minnesota NCORP Minneapolis Minnesota 55426
University of Rochester Rochester New York 14642
Columbus NCORP Columbus Ohio 43215
Dayton Oncology Research Program Dayton Ohio 45420

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02556632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02556632 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →